ReShape Lifesciences, Inc.

Q1 2023 13F Holders

Symbol
RSLS
CUSIP
76090R200
Type
Equity
Class
COM
Num filings
14
Total reported value, excl. options
$371 k
Manager Report Date Value ($000) Shares Option Type